Lincobel
Lincobel
Authorised
- Lincomycin hydrochloride monohydrate
Product identification
Medicine name:
Lincobel
Active substance:
- Lincomycin hydrochloride monohydrate
Target species:
-
Dog
-
Cat
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Lincomycin hydrochloride monohydrate113.40/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
Cat
-
Pig
-
Meat and offal7day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
- Bela-Pharm GmbH & Co. KG
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 15802.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 7/01/2025
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 7/01/2025
How useful was this page?:
